US-based clinical trial of oral exenatide capsules [ORMD 0901] for type 2 diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 29 Nov 2016 According to an Oramed Pharmaceuticals media release, the company anticipates initiating this phase IIb study in 2017.
- 03 Sep 2013 Oramed Pharmaceuticals has submitted a pre-IND package to the US FDA, which includes information on a clinical trial outline for this study, according to a company media release.
- 31 Jul 2013 New trial record